Inhibition of Human Dendritic Cell Activation by Hydroethanolic But Not Lipophilic Extracts of Turmeric (Curcuma longa)

Abstract

Turmeric has been extensively utilized in Indian and Chinese medicine for its immune-modulatory properties. Dendritic cells (DCs) are antigen-presenting cells specialized to initiate and regulate immunity. The ability of DCs to initiate immunity is linked to their activation status. The effects of turmeric on human DCs have not been studied. Here we show that hydroethanolic (HEE) but not lipophilic ”supercritical” extraction (SCE) of turmeric inhibits the activation of human DCs in response to inflammatory cytokines. Treatment of DCs with HEE also inhibits the ability of DCs to stimulate the mixed lymphocyte reaction (MLR). Importantly, the lipophilic fraction does not synergize with the hydroethanolic fraction for the ability of inhibiting DC maturation. Rather, culturing of DCs with the combination of HEE and SCE leads to partial abrogation of the effects of HEE on the MLR initiated by DCs. These data provide a mechanism for the anti-inflammatory properties of turmeric. However, they suggest that these extracts are not synergistic and may contain components with mutually antagonistic effects on human DCs. Harnessing the immune effects of turmeric may benefit from specifically targeting the active fractions.

Key words

dendritic cells - turmeric - curcumin - inflammation - Curcuma longa - Zingiberaceae

References

• 1 Jagetia G C, Aggarwal B B. ”Spicing up” of the immune system by curcumin.  J Clin Immunol. 2007;  27 19-35
• 2 Aggarwal B B, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold.  Adv Exp Med Biol. 2007;  595 1-75
• 3 Sandur S K, Pandey M K, Sung B, Ahn K S, Murakami A, Sethi G. et al . Curcumin, demethoxycurcumin, bisdemothoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism.  Carcinogenesis. 2007;  28 1765-73
• 4 Kurup V P, Barrios C S, Raju R, Johnson B D, Levy M B, Fink J N. Immune response modulation by curcumin in a latex allergy model.  Clin Mol Allergy. 2007;  5 1
• 5 Ranjan D, Chen C, Johnston T D, Jeon H, Nagabhushan M. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling.  J Surg Res. 2004;  121 171-7
• 6 Banchereau J, Steinman R M. Dendritic cells and the control of immunity.  Nature. 1998;  392 245-52
• 7 Dhodapkar K M, Kaufman J L, Ehlers M, Banerjee D K, Bonvini E, Koenig S. et al . Selective blockade of inhibitory Fc gamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells.  Proc Natl Acad Sci USA. 2005;  102 2910-5
• 8 Dhodapkar M V, Steinman R M, Sapp M, Desai H, Fossella C, Krasovsky J. et al . Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.  J Clin Invest. 1999;  104 173-80
• 9 Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E. et al . Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions.  Eur J Immunol. 1997;  27 3135-42
• 10 Kim G Y, Kim K H, Lee S H, Yoon M S, Lee H J, Moon D O. et al . Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets.  J Immunol. 2005;  174 8116-24
• 11 Kumar A, Dhawan S, Hardegen N J, Aggarwal B B. Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation.  Biochem Pharmacol. 1998;  55 775-83
• 12 Coussens L M, Werb Z. Inflammation and cancer.  Nature. 2002;  420 860-7